Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1999 1
2002 1
2003 6
2004 5
2005 3
2006 4
2007 4
2008 7
2009 5
2010 8
2011 11
2012 13
2013 14
2014 3
2015 13
2016 7
2017 8
2018 12
2019 8
2020 8
2021 8
2022 12
2023 12
2024 4

Text availability

Article attribute

Article type

Publication date

Search Results

166 results

Results by year

Filters applied: . Clear all
Page 1
In vitro and in silico studies reveal antidiabetic properties of arylbenzofurans from the root bark of Morus mesozygia Stapf.
Olufolabo KO, Lüersen K, Oguntimehin SA, Nchiozem-Ngnitedem VA, Agbebi EA, Faloye KO, Nyamboki DK, Rimbach G, Matasyoh JC, Schmidt B, Moody JO. Olufolabo KO, et al. Among authors: schmidt b. Front Pharmacol. 2024 Feb 23;15:1338333. doi: 10.3389/fphar.2024.1338333. eCollection 2024. Front Pharmacol. 2024. PMID: 38482058 Free PMC article.
Monitoring underwater volcano degassing using fiber-optic sensing.
Caudron C, Miao Y, Spica ZJ, Wollin C, Haberland C, Jousset P, Yates A, Vandemeulebrouck J, Schmidt B, Krawczyk C, Dahm T. Caudron C, et al. Among authors: schmidt b. Sci Rep. 2024 Feb 7;14(1):3128. doi: 10.1038/s41598-024-53444-y. Sci Rep. 2024. PMID: 38326378 Free PMC article.
Outcome of First-Line Treatment With Pembrolizumab According to KRAS/TP53 Mutational Status for Nonsquamous Programmed Death-Ligand 1-High (≥50%) NSCLC in the German National Network Genomic Medicine Lung Cancer.
Bischoff P, Reck M, Overbeck T, Christopoulos P, Rittmeyer A, Lüders H, Kollmeier J, Kulhavy J, Kemper M, Reinmuth N, Röper J, Janning M, Sommer L, Aguinarte L, Koch M, Wiesweg M, Wesseler C, Waller CF, Kauffmann-Guerrero D, Stenzinger A, Stephan-Falkenau S, Trautmann M, Lassmann S, Tiemann M, Klauschen F, Sebastian M, Griesinger F, Wolf J, Loges S, Frost N; National Network Genomic Medicine Lung Cancer (nNGM) Collaborator Group. Bischoff P, et al. J Thorac Oncol. 2023 Dec 13:S1556-0864(23)02423-1. doi: 10.1016/j.jtho.2023.12.015. Online ahead of print. J Thorac Oncol. 2023. PMID: 38096950 Free article.
Photoresponsive Supramolecular Cages and Macrocycles.
Nieland E, Voss J, Schmidt BM. Nieland E, et al. Among authors: schmidt bm. Chempluschem. 2023 Dec;88(12):e202300353. doi: 10.1002/cplu.202300353. Epub 2023 Sep 21. Chempluschem. 2023. PMID: 37638597 Review.
Assessment of efficacy and safety of endoscopic lung volume reduction with one-way valves in patients with a very low FEV1.
Sgarbossa T, Lenga P, Stanzel F, Holland A, Grah C, Gesierich W, Gebhardt A, Ficker J, Eggeling S, Andreas S, Schmidt B, Eisenmann S, Schwick B, Franke KJ, Fertl A, Witzenrath M, Hübner RH. Sgarbossa T, et al. Among authors: schmidt b. ERJ Open Res. 2023 Aug 21;9(4):00190-2023. doi: 10.1183/23120541.00190-2023. eCollection 2023 Jul. ERJ Open Res. 2023. PMID: 37609599 Free PMC article.
Overall Survival with Osimertinib in Resected EGFR-Mutated NSCLC.
Tsuboi M, Herbst RS, John T, Kato T, Majem M, Grohé C, Wang J, Goldman JW, Lu S, Su WC, de Marinis F, Shepherd FA, Lee KH, Le NT, Dechaphunkul A, Kowalski D, Poole L, Bolanos A, Rukazenkov Y, Wu YL; ADAURA Investigators. Tsuboi M, et al. N Engl J Med. 2023 Jul 13;389(2):137-147. doi: 10.1056/NEJMoa2304594. Epub 2023 Jun 4. N Engl J Med. 2023. PMID: 37272535 Clinical Trial.
166 results